ESCRS - PO0656 - Descemet's Membrane Endothelial Keratoplasty In Corneal Endothelial Decompensation Secondary To Forceps Injury

Descemet's Membrane Endothelial Keratoplasty In Corneal Endothelial Decompensation Secondary To Forceps Injury

Published 2023 - 41st Congress of the ESCRS

Reference: PO0656 | Type: Free paper | DOI: 10.82333/9v15-at06

Authors: Ami Igarashi* 1 , Takahiko Hayashi 1 , Toshiki Shimizu 1 , Kentaro Yuda 2 , Akira Kobayashi 3 , Satoru Yamagami 1

1Nihon University School of Medicine,Tokyo,Japan, 2Kikuna Yuda Eye Clinic,Yokohama,Japan, 3Kanazawa University Graduate School of Medical Science,Kanazawa,Japan

Purpose

To present the clinical outcomes of Descemet's membrane endothelial keratoplasty (DMEK) in a series of patients with corneal endothelial decompensation secondary to obstetric forceps injury.

Setting

Multicenter, retrospective case series.

Methods

Three eyes of three patients (mean age 64.3 years old) with a late complication of forceps delivery were included in this study. In all eyes, slit-lamp examination demonstrated vertical Descemet’s membrane breaks and corneal edema. For all patients, the medical history was significant for forceps delivery, and the examination findings were consistent with forceps injuries. DMEK was performed in all cases. All the patients underwent the following ophthalmological examinations before DMEK and at the follow-up visit, including best-corrected visual acuity (BCVA; converted to logarithm of the minimum angle of resolution [logMAR]), intraocular pressure (IOP), endothelial cell density (ECD), central corneal thickness (CCT).

Results

Mean BCVA improved from 0.47 logMAR, preoperatively, to 0.13 logMAR at 3 months postoperatively, and 0.07 logMAR at 6 months postoperatively. The mean postoperative ECD was 1903 cells/mm2 at 6 months (Mean ECD at baseline, 3167 cells/mm2). No postoperative complications were observed, and corneal transparency was maintained during the follow-up.

Conclusions

This study suggests that DMEK can be performed uneventfully with fair clinical outcomes in eyes with forceps corneal injury.